NCT05888493
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05888493
Title A Phase III Trial Comparing Tisagenlecleucel to Standard of Care (SoC) in Adult Participants With r/r Follicular Lymphoma (LEDA)
Acronym LEDA
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SVK | ROU | POL | HUN | ESP | CZE | CAN | AUT | AUS

Facility Status City State Zip Country Details
TRIHEALTH Good Samarithan Hospital RECRUITING Cincinnati Ohio 45220 United States Details
VA Tennessee Valley Healthcare System RECRUITING Nashville Tennessee 37212 United States Details
Novartis Investigative Site RECRUITING Camperdown New South Wales 2050 Australia Details
Novartis Investigative Site RECRUITING Clayton Victoria 3168 Australia Details
Novartis Investigative Site RECRUITING Melbourne Victoria 3004 Australia Details
Novartis Investigative Site RECRUITING Nedlands Western Australia 6009 Australia Details
Novartis Investigative Site RECRUITING Linz 4020 Austria Details
Novartis Investigative Site RECRUITING Salzburg 5020 Austria Details
Novartis Investigative Site RECRUITING Toronto Ontario M5G 2M9 Canada Details
Novartis Investigative Site RECRUITING Montreal Quebec H1T 2M4 Canada Details
Novartis Investigative Site RECRUITING Ostrava Poruba 708 52 Czechia Details
Novartis Investigative Site RECRUITING Budapest H-1097 Hungary Details
Novartis Investigative Site RECRUITING Poznan Greater Poland Voivodeship 60-355 Poland Details
Novartis Investigative Site RECRUITING Gliwice Silesian Voivodeship 44-101 Poland Details
Novartis Investigative Site RECRUITING Gdansk 80-952 Poland Details
Novartis Investigative Site RECRUITING Lodz 93 513 Poland Details
Novartis Investigative Site RECRUITING Bucharest 022328 Romania Details
Novartis Investigative Site RECRUITING Singapore 119074 Singapore Details
Novartis Investigative Site RECRUITING Bratislava 83310 Slovakia Details
Novartis Investigative Site RECRUITING Seoul 03080 South Korea Details
Novartis Investigative Site RECRUITING Seoul 03722 South Korea Details
Novartis Investigative Site RECRUITING Seoul 05505 South Korea Details
Novartis Investigative Site RECRUITING Seoul 06351 South Korea Details
Novartis Investigative Site COMPLETED Seoul 06591 South Korea Details
Novartis Investigative Site RECRUITING Santiago Compostela A Coruna 15706 Spain Details
Novartis Investigative Site RECRUITING L'Hospitalet de Llobregat Barcelona 08907 Spain Details
Novartis Investigative Site RECRUITING Santander Cantabria 39008 Spain Details
Novartis Investigative Site RECRUITING Salamanca Castille and León 37007 Spain Details
Novartis Investigative Site RECRUITING Barcelona Catalonia 08035 Spain Details
Novartis Investigative Site RECRUITING El Palmar Murcia 30120 Spain Details
Novartis Investigative Site RECRUITING Barcelona 08041 Spain Details
Novartis Investigative Site RECRUITING Córdoba 14004 Spain Details
Novartis Investigative Site RECRUITING Madrid 28034 Spain Details
Novartis Investigative Site RECRUITING Kaohsiung City 83301 Taiwan Details
Novartis Investigative Site RECRUITING Taichung 407219 Taiwan Details
Novartis Investigative Site RECRUITING Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field